Skip to content
Psychiatrist.com Logo
  • JCP
  • PCC
  • Insights
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Advanced Search

Menu

  • JCP
  • PCC
  • Insights
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Sign in Subscribe

Clinical Topics

View All
  • Addiction
  • ADHD
  • Alzheimer’s Disease
  • Anxiety
  • Bipolar Disorder
  • Depression
  • Movement Disorders
  • Neurology
  • OCD
  • Psychopharmacology
  • PTSD and Trauma
  • Schizophrenia/Schizoaffective Disorders
  • Sleep
  • Tardive Dyskinesia
  • View All

Collections

View All
  • Academic Highlights
  • Clinical & Practical Psychopharmacology
  • Early Career Psychiatrists
  • Evolving Psychedelic Paradigm
  • Focus on Childhood and Adolescent Mental Health
  • Focus on Geriatric Psychiatry
  • Focus on Psychotherapy
  • Focus on Suicide
  • Focus on Psychosis
  • Focus on Women’s Mental Health
  • JCP Podcast
  • Rounds in the General Hospital
  • View All

The Primary
Care Companionfor CNS Disorders

Volume 28 • 2026 • 6

Back to top Open menu arrow
Archive Volume 28 Current Issue

Original Research

PCC
Efficacy of Lumateperone 42 mg in Major Depressive Disorder: Subgroup Analysis of a Phase 3 Randomized, Placebo-Controlled Trial
Original Research

Efficacy of Lumateperone 42 mg in Major Depressive Disorder: Subgroup Analysis of a Phase 3 Randomized, Placebo-Controlled Trial

Prim Care Companion CNS Disord 2026;28(6):26m04289

Suresh Durgam, MD; Willie R. Earley, MD; Raffaele Migliore, MA; Hassan Lakkis, PhD; Roger S. McIntyre, MD; Maurizio Fava, MD
PCC
Prescription Patterns in Canadian Operational Stress Injury Clinics: An In-Depth Examination of Posttraumatic Stress Disorder Treatment Practices
Original Research

Prescription Patterns in Canadian Operational Stress Injury Clinics: An In-Depth Examination of Posttraumatic Stress Disorder Treatment Practices

Prim Care Companion CNS Disord 2026;28(6):26m04242

Jenny J. W. Liu, PhD; Erin Collins, PhD; Natalie Ein, PhD; Dominic Gargala, BSc; Anthony Nazarov, PhD; Tri Le, BHSc; Bethany Easterbrook, PhD; Edouard Auger, MD, FRCPC; Ken Balderson, MD, CM, FRCPC; Mathieu Bilodeau, MD, FRCPC; Amer M. Burhan, MBChD, MSc, FRCPC; Vicky Lavoie, PhD; Natalie Mota, PhD; Sonya G. Wanklyn, PhD, C.Psych; Mind PTSD Collaborative; J. Don Richardson, MD, FRCPC

Case Report

PCC
Nephophobia: A Case of Specific Phobia of White Clouds Coexisting With Acrophobia
Case Report

Nephophobia: A Case of Specific Phobia of White Clouds Coexisting With Acrophobia

Prim Care Companion CNS Disord 2026;28(6):26cr04287

Saurabh Chaudhary, MD; Shobit Garg, MD
PCC
Bovine-Derived Adrenal Cortex Supplement Self-Medication for Benzodiazepine Withdrawal
Case Report

Bovine-Derived Adrenal Cortex Supplement Self-Medication for Benzodiazepine Withdrawal

Prim Care Companion CNS Disord 2026;28(6):26cr04286

Sayed Abullaice Munshi, MBBS; Sourav Khanra, MD; Nishant Goyal, MD

Insightful. Evidence-based. Human-centered.

Listen Now
Psychiatrist Steven Berkowitz, MD, discusses psychedelic medicine for trauma treatment

Subscribe to read
more articles

Subscribe
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

ELSEWHERE:

  • ABOUT
  • ADVERTISERS
  • MEDIA RELATIONS
  • REPRINTS & PERMISSIONS
  • CONTACT US
  • CUSTOMER SUPPORT

FOLLOW US:

  • X
  • FACEBOOK
  • INSTAGRAM
  • LINKEDIN
  • THREADS
  • BLUESKY
  • SIGN IN

  • JOIN THE EMAIL LIST


SUBSCRIBE NOW
An image of the Psychiatrist.com logo mark
  • Privacy Policy
  • Terms of Use
  • Physicians Postgraduate Press, Inc.
  • JCP ISSN: Online 1555-2101, Print 0160-6689
  • PCC ISSN: Online 2155-7780, Print 2155-7772
  • MedFair.com US Patent No. 684794
  • © Copyright 2026 | Physicians Postgraduate Press, Inc. | LifeLong Learning For Clinicians
  • Sitemap